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Abstract 
The uterine adenocarcinoma is a slow growing malignant tumour that affects 50-80% of pet 
rabbits over 4 years old, having age as its major risk factor.  
The mechanisms underlying the development of this tumour are not completely understood and 
some of the existing studies presented contradictory results. In fact, in rabbits there is not an 
adequate classification of these tumours and until now the cellular and molecular features were 
not fully investigated.  
Regarding treatment and until today, ovariohysterectomy is the only effective treatment. Without 
it, this neoplasia leads to the female rabbit’s death within 1 to 2 years after the appearance of 
symptoms and metastasis. In spite of the fact that these tumours could in other species be treated 
by chemotherapy, radiotherapy and hormonal therapy, in rabbits these treatments were mainly 
used in laboratory animals and therefore, there is no data regarding the adequate protocol. 
The limited studies available and the existing doubts around the development of the uterine 
adenocarcinoma in rabbits show that further investigation is necessary to provide other ways to 
make an accurate diagnosis, to establish an adequate treatment protocol and to determine the 
prognosis.  
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Resumo 
O adenocarcinoma uterino é um tumor maligno de crescimento lento que afecta 50-80% dos 
coelhos com mais de 4 anos, sendo a idade o principal factor de risco para esta neoplasia. 
Os mecanismos que envolvem o desenvolvimento deste tumor não estão totalmente clarificados 
e alguns estudos apresentam resultados contraditórios. Actualmente, a classificação bem como 
a caracterização celular e molecular do adenocarcinoma uterino nesta espécie permanece pouco 
aprofundada. 
Até à data, a ovariohisterectomia é o único tratamento eficaz e, na sua ausência, o 
adenocarcinoma provoca a morte num período de 1 a 2 anos após o aparecimento de sintomas 
e metástases. Em diferentes espécies, a quimioterapia, a radioterapia e a terapia hormonal são 
outras opções de tratamento, no entanto nos coelhos a sua aplicação é apenas experimental e 
associada a animais de biotério, não existindo informação suficiente para o estabelecimento de 
protocolos adequados à espécie. 
O número limitado de estudos e as permanentes dúvidas associadas ao desenvolvimento desta 
patologia em coelhos evidencia a necessidade de investimento na investigação, a qual poderá 
revelar novas formas de diagnóstico e tratamento e, consequentemente, alterar o prognóstico. 
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1. Introduction 
The domestic rabbit descends from the European rabbit, Oryctolagus cuniculus, which belongs 
to the Lagomorpha order.1 Since a few years, the rabbit that once was considered just a domestic 
animal for food purposes, is nowadays one of the modern day exotic pets, being the third most 
popular after dogs and cats.2–4 
There are more than 50 different breeds of domestic rabbits that vary from small to large and 
giant breeds. Although many of the pet rabbits belong to smaller breeds such as Dwarf lops, 
Dutch or English,1,3 the majority of the pet rabbits are mixed breeds.3  
A well cared house pet rabbit, fed a suitable diet and kept in a healthy environment has a lifespan 
of 8 to 12 years. An increased longevity is associated to the development of several tumours such 
as lymphoma, skin, bone and uterine tumours being the uterine adenocarcinoma one of the most 
frequent.5 In fact, previous studies reported that  in females over the age of 4 years, the 
endometrium undergoes a decrease in cellularity and an increase in the production of collagen, 
that seems to be associated with the development of uterine tumours.6,7 According to a study 
performed in 47 rabbits presenting uterine disorders, 21.3% of the rabbits presented uterine 
adenocarcinoma, while 8.5% of the rabbits presented leiomyoma.8 Moreover, in a recent study 
performed in 50 pet rabbits, uterine adenocarcinoma was detected in 27 out of the 50 rabbits 
(54%) and 18% of the rabbits presented simultaneously two or three types of uterine disorders.9 
Adenoma, leiomyosarcoma, carcinosarcoma, choriocarcinoma, malignant mixed müllerian 
tumour and hemangioma are other types of tumours that have been described in pet rabbits.9,10  
Altogether, the published results indicated that uterine adenocarcinoma is the most frequently 
diagnosed malignant tumour of the female rabbit with an incidence that may reach 79.1% in 
rabbits with 5 to 6 years old.11 Considering that rabbits are one of the most popular pets, that 
uterine adenocarcinoma is the most prevalent tumour among female rabbits and the survival rate 
after diagnosis is reduced, the present review aims to provide the current state in the diagnosis 
and treatment of the rabbit uterine adenocarcinoma.  
 
 
2. Anatomy and physiology of the reproductive system 
Anatomically, lagomorphs present two uterine horns and two cervices, one for each horn, which 
open separately into an elongated vagina (Figure 1. and 2.).3,12,13 The uterine body is inexistent 
or not distinct in this species.3,12 The ovaries are usually surrounded by fat and are not in a true 
ovarian bursa.13 The uterus can be palpated in the ventral abdomen, caudally to the caecum1 and 
the bladder is positioned ventrally to the uterine horns.13 
Rabbits are very prolific and are able to reproduce early in their lives. The stage of puberty begins 
at 4-6 months of age depending on the size of the breed (the smaller, the earlier) and its 
reproductive life goes up to 4 years of age, approximately.1,3 Rabbits, like cats and ferrets, are 
considered induced ovulators, and do not present a regular oestrus cycle with defined periods of 
heat in which the female ovulates spontaneously.1,14 In fact, female rabbits are considered to be 
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in oestrus almost permanently (Table 1.).14 Nonetheless, a cyclic rhythm exists and variety in 
sexual receptivity can occur among females.1  
The female rabbit is receptive to the male when the follicle stimulating hormone (FSH) stimulates 
the mature ovarian follicles to produce oestrogens, which may take 12 to 14 days.1 During this 
period, if mating does not occur, the follicles will degenerate and a decrease in oestrogen level 
and sexual receptivity to the male rabbit will happen, followed by maturation of new ovarian 
follicles. Therefore, the female rabbit presents a period of receptivity that lasts 12-14 days, 
succeeded by 1-2 days of non-receptivity to the male.1,14 Full sexual receptivity happens every 
18 days.1 This cyclic rhythm may be influenced by different factors such as light, temperature, 
nutrition, sexual stimulation and individual variation.1 When mating does occur, ovulation is 
induced by the mounting 10 to 12 hours post-coitus1,2,14, causing the release of luteinizing 
hormone (LH) from the pituitary gland.14 Besides mounting, ovulation can also be induced by 
mechanical stimulation of the vagina1,14, mounting by other females and proximity of an entire 
male.1  
 
 
Figure 1. The female rabbit reproductive organs. Original scheme 
Right uterine horn Left uterine horn 
Ovaries 
Oviduct 
Pavillion 
Two cervices 
Vagina 
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Figure 2. Detail of the two cervices of a rabbit that underwent ovariohysterectomy.  
Courtesy of Dr. Neus Morera, Clinica Veterinaria Exótics, Barcelona, Spain. 
 
Table 1. Physiological and reproductive data regarding the rabbit.  
Rabbit physiological data 
Life Span 6-10+ years 
Adult Body Weight 
Female: 2-6 kg (depending on 
breed) 
Male: 2-5 kg (depending on breed) 
Rectal Temperature 38,5ºC – 40ºC 
Heart Rate 130-325 bpm 
Respiratory Rate 32-60 rpm 
Blood Volume 55-70 ml/kg 
Dental Formula 2-0-3-3 / 1-0-2-3 
Rabbit reproductive data 
Puberty 
Small breeds: 4-5 months 
Large breeds: 5-8 months 
Oestrus Cycle Induced ovulatory 
Gestation 30-32 days 
Litter Size 5-8 (average) 
Birth Weight 40-100 g 
Weaning 4-6 weeks 
Breeding Duration 1-3 years 
Adapted from Harcourt-Brown (2002), Mitchell et al. (2009) and Johnson-Delaney (2008). 
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3. Uterine adenocarcinoma 
The adenocarcinoma of the uterus is a slow growing malignant tumour having its origin in the 
epithelial cells of the deep glandular portion of the endometrium.15,16 Recently, several studies 
pointed that in addition to mature epithelial cells there is a small subpopulation of malignant 
tumour cells with a high proliferative potential and with the capacity to self-renew and  differentiate 
termed cancer stem cells (CSCs), that may initiate and maintain the uterine adenocarcinoma17–
19. The CSCs have a high proliferative potential, an increased resistance to death and an 
increased ability to migrate, properties that confer to the tumour a bigger potential to metastasize 
and to resist to chemotherapy and radiation therapy. In spite of the fact that CSCs are mainly 
studied in humans, recent studies pointed that CSCs are a common feature across solid tumours 
from different tissues and species and therefore should also be considered in future studies of 
the rabbit uterine adenocarcinoma.17,20  
Regarding the ability to metastasize, the uterine adenocarcinoma starts to invade the 
myometrium, extending to the uterine wall and to the surround structures of the peritoneal 
cavity.6,21 Due to the uterus rich blood supply, haematogenous metastatic spread to distant 
locations such as the lungs and liver is frequent and in a late phase, within 1 to 2 years, the 
metastatic spread may reach the brain, bones and skin.3,5,6,9,21,22 The rabbit’s life span between 
the appearance of symptoms and death by metastasis is approximately6,22 1 to 2 years without 
treatment.22 
 
3.1 Epidemiology and risk factors 
In female rabbits, the uterine adenocarcinoma is the most common tumour being diagnosed with 
an incidence of 50-80% in animals over 4 years old.3,6,7 Tumours in production and laboratory 
rabbits are practically inexistent due to these animals short period of life.23 There is no difference 
in the incidence of adenocarcinoma in breeding vs. nonbreeding rabbits.22 
 
3.1.1 Age 
Previous studies reported that in rabbits under 3 years of age the incidence was approximately 
4%, whereas in rabbit age 5 to 6 years the incidence was 79.1%.8,23 This increased incidence 
with age seems to be associated to age-related changes that occur progressively in the 
endometrium, turning it less cellular and more collagenous.6,23,24 This process is usually called 
senile atrophy.15,23 In fact, several studies reported that these alterations may underlie the 
transition to endometrial hyperplasia, followed by uterine adenocarcinoma (Figure 3.).23 
Nevertheless, this theory is not consensual since Asakawa et al. pointed that progression from 
cystic endometrial hyperplasia to adenocarcinoma is not always detected.11  
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Figure 3. Age distribution of rabbits with adenocarcinoma (n=17) or concurrent adenocarcinoma and 
endometrial hyperplasia (n=9). Adapted from Walter et al. (2010). 
 
3.1.2 Breed 
Although most races may present adenocarcinomas, there are breeds that have a higher 
incidence which seems to indicate an increased susceptibility to the development of this tumour.25 
An extensive study performed by Greene et al. showed that the Tan breed was the one which 
presented a higher incidence of uterine adenocarcinoma (50% of rabbits were affected).15 The 
Silver breed had an incidence of 25% followed by the Havana breed with an incidence of 22% 
and by the Dutch breed with an incidence of 20% (Figure 4.). In other breeds, such as Polish, 
Himalayan, Sable, Beveren, Chinchilla, English and Marten, the incidence is low, varying between 
8% and 17%.15,24 In breeds such as Rex and Belgian this neoplasia has not been reported.23,24 
This data was collected from a colony of 849 rabbits, observed for 9 years, with a tumour 
incidence of 79% in 5 year-old animals.15  
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Figure 4. Incidence of uterine adenocarcinoma in different breeds according to a study by Green et al. 
Adapted from Baba et al. (1972). 
 
3.1.3 Hormones 
Hormonal related risk factors such as pseudopregnancy, pregnancy toxaemia and obesity remain 
controversial.23 Several studies pointed that oestrogens may contribute to the development of 
uterine adenocarcinoma.8,24,25 Nevertheless, Baba et al. also pointed that the administration of 
oestrogens to aged female Dutch laboratory rabbits with a transplanted tumour reduced the 
incidence of endometrial carcinoma from 17% to 3%.15 In addition, a recent study suggested that 
the hormone progesterone may not be directly involved in neoplastic transformation, but may be 
involved in the modulation of the proliferative activity of the endometrial tissue.25 Therefore, more 
studies are needed in order to clarify the contribution of sexual hormones to the development of 
uterine adenocarcinoma. 
 
a. Pseudopregnancy 
In a mature female, pseudopregnancy is common25 and is characterized by the maintenance 
of the corpora lutea for a prolonged period of time, leading to secretion of progesterone in the 
absence of fetuses.25 This condition mimics a true pregnancy, even though it lasts 16-18 days 
rather than 31-32 days of a true pregnancy.1 In case of pseudopregnancy, the endometrium 
undergoes a continuous hormonal stimulation that can predispose to the development of 
uterine tumours.23,25  
 
b. Pregnancy toxemia 
According to a study24, all rabbits that experienced pregnancy toxaemia have also developed 
uterine tumours later. Pregnancy toxaemia is characterized by a development of ketosis in 
Dutch Havana Silver Tan
22%
50% 
20% 
25% 
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late pregnancy or during early lactation, when glucose is needed the most.5 It is most 
frequently seen in overweight females.2 This condition leads to a drop in blood glucose which 
stimulates the mobilization of fatty acids from the adipose tissue to the liver, developing 
hepatic lipidosis and sometimes liver failure.26 It was hypothesised that due to the liver failure, 
there is a significant increase in the oestrogens levels in circulation which may contribute to 
the development of uterine adenocarcinoma.24 
 
c. Obesity 
Although in rabbits, there is not much information regarding the direct association of obesity 
and the development of uterine adenocarcinoma, in humans, obesity is a well-known risk 
factor.  
Obesity in rabbits is common and according to the Rabbit Clinic of the University of Edinburgh, 
1 in 4 rabbits visiting the clinic is obese 27. 
Rabbits presenting this condition are more predisposed to health problems, showing an 
increased risk of cardiovascular diseases, hyperglycaemia, high cholesterol and 
consequently hepatic lipidosis, amongst other complications 27,28. Also, overweight rabbits are 
poor surgical candidates28, leading to a more difficult treatment in case of uterine 
adenocarcinoma. 
In humans, the excess of body weight is associated with an increased risk of endometrial 
tumours in postmenopausal women since the adipocytes have an endocrine function in 
addition to fat storage.29 Adipocytes secrete cytokines and growth factors and play a 
significant role in the modulation of the oestrogens levels through aromatase.29,30 Aromatase 
is an enzyme present in the adipose tissue that converts testosterone into oestrogen, inducing 
cell proliferation in oestrogen receptor positive tissues such as endometrial and breast tumour 
tissue.30 In rabbits the association between adipose tissue and the expression of aromatase 
was not evaluated. However, considering the genotypic homologies it is possible to 
hypothesise that a similar cellular and molecular mechanism may occur in obese rabbits and 
also that these rabbits are probably under an increased risk to develop uterine 
adenocarcinoma.  
 
 
3.2 Macroscopic characteristics  
The uterine adenocarcinoma has been described grossly as solid, firm, often presenting 
multicentric nodules, seen in one or both uterine horns which can be moderately to severely 
enlarged.8,15,31,32 Two authors reported a cauliflower-like growth on the cut surface of the tumour6,8 
and others also described the adenocarcinoma as one or more globular polypoid structures with 
projection to the uterine lumen.32 The centre of the tumour can often be necrotic, haemorrhagic 
or mucinous.22 Formation of intra-nodular cysts and adhesion to proximal tissue and abdominal 
organs was also observed (Figure 5.).31  
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Macroscopically, it is also possible to put in evidence the non-encapsulated and infiltrative 
characteristics of this tumour.25,33,34 Due to this infiltrative ability, metastasis in the mediastinum, 
diaphragm and lung lobes have been described as “numerous firm, smooth, white, glistening, 
poorly demarcated nodules with a white, smooth and flat cut surface”, by Zadravec et al. (Figure 
6.).10  
 
 
Figure 5. Multiple nodules in both uterine horns of a rabbit. 
 Courtesy of Dr. Neus Morera, Clinica Veterinaria Exótics, Barcelona, Spain. 
 
 
Figure 6. Metastatic disease in the lungs of a rabbit with uterine adenocarcinoma.  
Courtesy of Dr. Neus Morera, Clinica Veterinaria Exótics, Barcelona, Spain. 
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3.3 Microscopic characteristics 
 
3.3.1 Histological characteristics 
Histologically, the epithelial cells of the rabbit uterine adenocarcinoma have been characterized 
as cuboidal, columnar or polygonal presenting indistinct cell borders and an eosinophilic or 
basophilic cytoplasm.25,31 The nuclei can be round to oval with a variable dimension and nuclear 
anisokaryosis and pleomorphism have been described.6,35,36The mitotic index was variable 
amongst studies.8,11,25,33,34  
Infiltrations of eosinophils, areas of necrosis, cellular debris and haemorrhage were also 
described in association with the adenocarcinoma.6,25,33 Aggregates of lymphocytes and plasma 
cells at the periphery of the tumour have also been identified.33  
Regarding tumour growth architecture and tumour cellular organization, several patterns have 
been described. In fact, much like canine tumour classification37, growth patterns such as tubular, 
solid, cystic, papillary and comedo-type were observed in the rabbit uterine adenocarcinoma. 
Although different growth patterns can coexist in the same tumour, according to several studies, 
a tubulopapillary growth pattern is usually dominant and characterized by neoplastic epithelial 
cells arranged irregularly in multilayers supported by a fibrous stroma.26,39,36,37 In effect, in a study 
presenting 42 cases of uterine adenocarcinomas, 26 had a papillary growth pattern (Figure 7.) 
and 16 had a tubular growth pattern (Figure 8.).11  
This classification, according to the growth pattern, is substantially different from the one used in 
human endometrial tumours, which is based in a grading system that takes in consideration the 
similarity between glands from tumour form and glands from normal endometrium. Grade 1 
endometrial tumours present 95% or more of the tumour tissue forming glands while in Grade 2, 
50% to 94% of the tumour tissue is forming glands. Tumours included in these grades are 
considered low grade and are classified as Type 1. Grade 3 represents tumours that have less 
than half of its tissue forming glands and are considered high grade tumours. These tend to be 
more aggressive in comparison with low grade tumours and are classified as Type 2.40 Type 1 
endometrial tumours are considered oestrogen-dependent, presenting a high expression of 
oestrogen and progesterone receptors. These type of tumours  spread slowly to other tissues and 
have a favourable prognosis.41,42 Type 1 tumours are the most common, representing 80-85% of 
cases. On the other hand, Type 2 endometrial tumours are less common, representing only 10-
15% of cases. They are not hormone dependent and have a bigger tendency to spread to other 
organs, leading to a poorer prognosis. 41,42 
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Figure 7. Papillary adenocarcinoma of a female rabbit. HE. 
Courtesy of M. G. Asakawa from Asakawa et al. (2008) 
 
 
Figure 8. Tubular adenocarcinoma of a female rabbit. HE. 
Courtesy of M. G. Asakawa from Asakawa et al. (2008) 
 
3.3.2 Immunohistochemical characteristics 
Nowadays, the macroscopic evaluation and the microscopic study of tumours is not complete 
without the study of the expression of molecular markers by immunohistochemistry. This study 
allows a better characterization of the tumour cells and consequently to set an adequate treatment 
and in some cases the establishment of a prognosis.  
In rabbits, only a few authors tried to characterize the uterine adenocarcinomas through 
immunohistochemistry. The most frequent molecular markers reported in the previous studies 
were protein Ki-67, calponin, vimentin, tumour protein 63 (P63), cytokeratin 19 (CK19), and 
cytokeratins AE1/AE3. 43,25  
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a. Protein Ki-67 
Ki-67 is a nuclear protein strictly associated with cell proliferation. This protein is present in 
all the active phases of the cell cycle but it is absent from the resting cells. This characteristic 
makes it an excellent marker for determining the so-called growth fraction of a given cell 
population. Although the Ki-67 protein is well characterized on the molecular level and 
frequently used as a proliferation marker, its functional significance still remains unclear. 44  
 
b. Calponin 
Calponin is an Actin- and Tropomyosin-binding protein that acts as an inhibitory factor of 
smooth muscle actomyosin activity. It regulates smooth muscle cell contraction and it is a 
marker of smooth muscle differentiation and therefore it is useful to distinguish 
adenocarcinoma from smooth muscle tumours.45  
 
c. Vimentin 
Vimentin is a constituent of the protein intermediate filament family of proteins, contributes to 
the cellular integrity and provides resistance against stress. It is frequently used as a 
myoepithelial and mesenchymal cells marker. More recently, vimentin has also been 
associated to undifferentiated tumour  cells.43 Several studies reported that the expression of 
vimentin is increased in several epithelial tumours and also that its expression is associated 
to more aggressive tumours, to an higher ability to invade tissues and to a poor prognosis.46 
 
d. Protein 63 (P63) 
P63 is considered a marker of myoepithelial and of basal cells from the stratified epithelia and 
seems to contribute to the epithelial development in several organs. Previous studies pointed 
that loss of the p63 expression frequently occurs in endometrial carcinoma and also that this 
loss is associated to an increased agressivity of the tumours cells. 47,48 
 
e. Cytokeratin 19 (CK19) 
Cytokeratins constitute a subgroup of intermediate filament proteins and are divided into two 
types: acidic type I (CK9-CK20) and basic type II (CK1-CK8) keratins. These proteins form 
the cytoskeleton of epithelial cells and their main function is to maintain the epithelial cell 
integrity. Therefore, epithelial cells usually express at least a type I and a type II keratin. CK19 
is one of the main keratins that has been used as marker of myometrial invasion and subtle 
foci of lympho-vascular space invasion.49 
 
f. Cytokeratin AE1/AE3 
The CKAE1 and AE3 are expressed during epithelial cell differentiation and are used for 
clinical determination of the epithelial origin of malignant cells such as the ones present on 
carcinomas.47 Regarding uterine adenocarcinoma it was reported that only the superficial 
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epithelial tumour cells evidenced positivity to the two CK, suggesting that they possibly 
originate from the endometrial surface epithelium.43  
 
In previous studies that evaluated 6 rabbits’ uterine adenocarcinomas, 83.3% of the 
adenocarcinomas were positive for CK19, whereas uterus with endometrial hyperplasia and 
normal endometrium presented a much lower expression of this marker. Also, positive labelling 
for Ki-67 was detected for both benign and malign tumours, including the adenocarcinoma, for 
which proliferation indices were 19.41±7.9%.25 
In addition to the evaluation of these markers, the study of the oestrogen receptor-α (ER-α) and 
progesterone receptors (PR) expression may also contribute to better understand the 
characteristics of the uterine adenocarcinoma. Considering the immune-reactive scores of ER-α 
and PR and the mode of myometrium invasion, a previous study proposed 2 different 
development patterns for uterine adenocarcinoma in the rabbit: a papillary growth pattern, which 
is negative for both ER-α and PR and a tubular growth pattern, which is positive to ER-α, PR or 
both (Table 2.). Regarding tumour invasion, this study also pointed that papillary 
adenocarcinomas infiltrated the myometrium later in the disease, whereas tubular 
adenocarcinomas invaded into the deep myometrium early in the disease.11 This classification 
could be compared to the one applied to humans, even though there are no studies supporting 
this idea. In spite of the scarce information regarding the expression of tumour markers, previous 
publications emphasize that the accurate evaluation of ER-α and PR and the establishment of a 
growth pattern may contribute to help determine the survival rate and to establish a selective 
therapy in the future. 
These and other tumour markers contribute to characterize tumours, to evaluate the proliferative 
potential of the tumour cells, to establish a more accurate treatment, to establish a prognosis and 
confirm the origin of metastases. Therefore, an effort should be made in order to perform a more 
consistent evaluation of the rabbit uterine adenocarcinoma. 
 
Table 2. Oestrogen and progesterone receptor expression in 42 uterine adenocarcinomas of rabbits.  
 
( n=) ER(+), PR(+) ER(+), PR(-) 
ER(-), 
PR(+) 
ER(-), PR(-) 
Adenocarcinoma 
(total) 
42 
14       
33.3% 
4         9.5% 2         4.8% 22      52.4% 
Papillary 
adenocarcinoma 
26 2         7.7% 2         7.7% 1         3.8% 21      80.8% 
Tubular 
adenocarcinoma 
16 
12       
75.0% 
2        12.5% 1         6.3% 1        6.3% 
Adapted from Asakawa et al. (2008). 
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4. Clinical signs 
Owners of female rabbits bearing uterine diseases frequently present complains about the 
presence of blood in the urine50, although in this cases blood originates in the uterus and is 
released when the rabbit urinates.9,10,22,50,51 Haematuria is intermittent and occurs more frequently 
at the end of the urination.22 In a recent study regarding uterine disorders in 50 pet rabbits, in 31 
out of the 50 rabbits, 71% presented a serosanguineous vaginal discharge or haematuria and/or 
an enlarged uterus during abdominal palpation. In the same study, uterine adenocarcinoma was 
detected in 27 out of the 50 rabbits studied.9 In another study, 68.1% of the rabbits also presented 
haematuria and the bleeding complaints in 8 of 10 cases corresponded to uterine 
adenocarcinoma.51 Together, the results from these studies pointed that bleeding, usually 
detected by the rabbit owner as haematuria, could be one of the cardinal symptoms in rabbit’s 
uterine disorders9. However, as it was demonstrated by Walter et al., the absence of bleeding 
does not exclude the existence of a uterine disorder. In fact, in a study with 59 rabbits that 
presented uterine disorders, only 10 presented bleeding.52 
Enlargement of the abdomen and abdominal pain are some of the unspecific predominant clinical 
signs.9 During abdominal palpation it is possible to palpate masses consistent with uterine 
adenocarcinoma in the caudal portion of the abdomen.9,50 In a study performed by Kunzel et al. 
in 31 pets with uterine disorders, 45.2% of the rabbits presented a palpable mass in the 
caudoventral portion of the abdomen and 22.6% of the rabbits presented abdominal pain during 
palpation. In the same study, clinical signs such as innapetence, lethargy, uneaten cecotrophs 
and dyspnea in patients with lung metastases were also found (Table 3.).9  
In another study with 47 rabbits, 15 (31.9%) of the rabbits presented mammary gland disorders 
in addition to uterine disorders.51 The association between uterine disorders and the occurrence 
of mammary gland disorders was confirmed in a recent study performed by Kreso et al. who 
reported that 30% of the rabbits with uterine tumours may also present mastitis and mammary 
gland tumours.22 These studies seem to emphasize the role of hormones in the development of 
both uterine and mammary tumours, since it has been proven in other species such as rats, dogs 
and humans that there is a direct correlation between oestrogen and progesterone receptors 
concentration in both uterine and mammary tissues53. 
Other unspecific symptoms such as decreased fertility, small litter size, pregnancy complications7 
and increased aggressiveness22 have been described. Also, complications like severe anaemia, 
rupturing of the uteri and adhesions to adjacent viscera can also occur as well.9 
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Table 3. Percentage of several clinical signs of 31 pet rabbits diagnosed with uterine disorders.  
Clinical Signs Percentage (%) 
Palpable mass 45.2 
Vaginal discharge/Haematuria 32.3 
Inappetence 32.3 
Abdominal pain 22.6 
Lethargy 19.4 
Uneaten cecotrophs 16.1 
Dyspnoea 12.9 
Adapted from Kunzel et al. (2015). 
 
5. Diagnosis 
Because of their prey instinct, rabbits have a tendency to mask their illnesses which requires an 
exhaustive and patient examination performed by the veterinarian in order to achieve a successful 
diagnosis.3 
The rabbit uterus lies caudally to the caecum in the ventral abdomen and when enlarged has a 
tendency to fall forward into the abdomen.28 In an initial phase, due to its small size, the uterine 
adenocarcinoma can be unnoticeable during general examination.50 When detected, the tumour 
may have up to 1 cm in diameter and if left without treatment can reach 5 cm in diameter within 6 
months, being easily palpable through the abdominal and uterine walls.23 
 
5.1 Differential Diagnosis 
Considering the main clinical signs described in Table 3, in addition to the uterine tumours3, 
several differential diagnoses should be taken into account when presented with a palpable mass 
in the ventral abdomen of a female rabbit, such as: pyometra3,22, hydrometra3, mucometra3, 
endometrial hyperplasia3, pregnancy3,22, pseudopregancy3,22 and endometrial venous 
aneurism2,22 (Figure 9.).  
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Figure 9. Differential diagnosis for a palpable mass in the ventral abdomen of a female rabbit. 
 
5.2 Diagnostic Procedures 
In rabbits with a clinically suspected uterine adenocarcinoma, a diagnostic workup is required in 
order to achieve a correct diagnosis. One of the main complementary diagnostic exams is  
imaging.9,50 Abdominal radiographs could be used to assess the reproductive system in case of 
a mass in the caudalventral abdomen. It is important to take at least two radiographs one in right 
lateral and the other ventrodorsal to achieve an adequate image of the mass 3. In rabbits 
presenting dyspnoea, thoracic radiographs can detect and diagnose metastatic neoplasia3,9 being 
this technique recommended to detect early metastases.22  
Another imaging technique proven to be useful in the diagnosis of uterine adenocarcinoma is the 
ultrasound. If a 7.5 to 10 MHz transducer is used it is possible to obtain quality images of the 
abdomen and thorax.3,9 Using this technique, alterations such as enlargement of the uterus’ 
diameter, fluid within the lumen, masses and alterations in echogenicity were found in all rabbits.9 
Although it has not been reported in rabbits, in humans, the use of computerized tomography 
(CT) is routinely used in the management of uterine tumours.54 
In a recent study, both radiography and ultrasonography were used. Abdominal radiography was 
performed in 11 out of the 50 rabbits and uterine alterations were detected in 8 out of the 11 
rabbits. The confirmation of the diagnosis was given by abdominal ultrasonography in 28 rabbits 
with possible uterine disorders. The authors,9 based on this results, consider abdominal 
Differencial 
Diagnosis
Uterine tumours
Pregnancy
Pseudopregnancy
Endometrial 
hyperplasia
Hydrometra
Mucometra
Piometra
Endometrial 
venous aneurism
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ultrasonography to be the most accurate method to diagnose uterine disorders such as the uterine 
adenocarcinoma.9   
In ambiguous cases of females presenting haematuria or serosanguineous vaginal discharge, an 
urine dipstick can be useful to differentiate blood from porphyrin-pigmented urine caused by plant 
pigments9 and can detect the presence of other cells like leucocytes.10 Ultrasound-guided 
cystocentesis can be used to differentiate haematuria from uterine blood.22 Also, an hematologic 
test or at least an haematocrit determination should be done due to the fact that, in more advanced 
cases, the rabbit can be anaemic due to blood loss.50 
The definite diagnosis is only confirmed by histopathology after ovariohysterectomy and removal 
of the masses. 6,8   
 
 
6. Treatment 
 
6.1 Surgical Treatment 
The treatment of choice in clinically stable rabbits with uterine adenocarcinoma is 
ovariohysterectomy.7,9,22,24,50,52 This surgical technique involves the removal of the reproductive 
tract of the animal.55  
Prior to the surgery, several unique features regarding the reproductive system of the female 
rabbit must be taken in consideration, such as the presence of two uterine horns and two cervices, 
one for each horn. The uterine body is not identified in the rabbit.55 Also, the mesometrium stores 
a great amount of fat, which can make it difficult to identify.12,55  Due to the fact that the uterus is 
localised in the abdominal cavity, care must be taken to avoid the caecum and bladder when 
making the abdominal incision.1 Some authors12,55 recommend expressing the bladder prior to 
surgery to avoid filling of the vagina with urine and possible contamination.  
In general, the rabbit uterus is fragile in comparison with other species such as dogs and cats, so 
it must be handled with care.12,55 
 
6.1.1 Anaesthesia and Analgesia 
For routine surgical procedures such as an ovariohysterectomy56, a combination of medetomidine 
(0,25 mg/kg SC IM)55, ketamine (15 mg/kg SC IM)55 and butorphanol (0,5 mg/kg SC IM)57,58 is 
recommended for the induction of anaesthesia and analgesia.55,58 At the end of the surgery, 
medetomidine should be reversed with its antagonist atipamezole55 (same volume SC or IM as 
medetomidine)57. 
Oxygen must be administrated prior to the intubation and during surgery.55 After loss of 
consciousness, intubation with the rabbit in ventral recumbency using a “blind technique” is 
recommended.55,58 Endotracheal intubation is difficult in this specie due to the fact that its anatomy 
does not permit the visualization of the nasopharynx or larynx.58 After the intubation, maintenance 
of the anaesthesia during the surgical procedure is guaranteed by the volatile anaesthetic 
isoflurane 1-3%.55,58,59  
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Monitoring of the patient must be constant.2 Respiration rate, depth and pattern are the best 
indicators of anaesthetic depth.58 Also, in a rabbit, the absence of an ear pinch and hind-leg 
withdrawal reflexes and loss of jaw tone are reliable indicators of surgical anaesthesia.2,58 Heart 
rate, colour of the mucous membranes and rectal temperature are other important aspects to take 
in consideration during the monitoring of an anaesthetised rabbit.58 
 
6.1.2 Surgical Technique – Ovariohysterectomy 
In female rabbits, the ovariohysterectomy is performed in dorsal recumbency via a ventral midline 
incision12,55,60, starting half way between the umbilicus and the pubic symphysis.12,56 Once the 
linea alba is exposed, before making the incision and in order to prevent perforation of abdominal 
organs, elevation of the body wall from the abdominal structures is recommended due to the fact 
that the caecum and bladder may be directly under the incision site12,55,56 Within the peritoneal 
cavity, identification of the uterus must be done60 and the cervices may be seen immediately after 
the incision.61 Elevate one of the uterine horns from the incision12 and follow it cranially to the 
ovary.61 The ovarian ligament can be detached manually for further exteriorization of the 
ovary.55,56 To tie off the ovarian blood vessels it is necessary to dissect through the fat and to 
pass a ligature around the portion containing the vessels supplying the ovary.12 Ligation of large 
blood vessels in the broad ligament of the uterus is frequently required.12,55 After the procedure 
is repeated in the contralateral uterine horn, the uterus should  then be ligate caudally to the 
cervices with a transfix ligature around the vagina side, in order to remove the cervices 
completely.12,60,61 This technique will carry a smaller risk of leaving uterine tissue and will 
consequently reduce the possibility of a tumour recurrence.56,61 Risks like incorporating the 
ureters and the bladder blood vessels in a misplaced ligature must be taken in consideration.56 
Also, due to the fact that the rabbit’s proximal aspect of the vagina fills with urine during micturition, 
leakage of urine through the vaginal stump can result in abdominal cavity contamination when 
the ligature is not securely performed.56,60,61 
During this procedure, inspection of the abdominal organs for metastasis should be done and, in 
case of any suspected metastasis, biopsy is recommended.3 If there are neoplastic mammary 
glands associated with the adenocarcinoma its removal should be done at the same time. Cystic 
breast changes such as cystic mastitis will reverse after the ovariohysterectomy.21,22 
Closure of the abdominal wall in three layers is routine12,60, with muscular wall, subcutaneous 
tissue and skin being closed as separated layers12, using an intradermal suture pattern with a 3-
0 absorbable suture is recommended.55,61  
To achieve a correct diagnosis, the organs and tissues removed during surgery must be fixated 
in a paraformaldehyde solution, dehydrated using alcohol solutions and embedded in paraffin to 
obtain paraffin sections. These sections will be stained with nuclear and cytoplasmic staining in 
order to determine the cellular characteristics of the tumour as well as the tumour architecture.6,24 
To obtain further characterization, the expression of molecular markers should be analysed, as 
previously described.  
 
18 
 
6.1.3 Postoperative Considerations 
When recovering from surgery, hypothermia, stress, anorexia and reduced gut motility are some 
of the possible symptoms that a small mammal like the rabbit can experience.58 Recovery time in 
a quiet, warm and comfortable environment is the key to achieve an adequate recovery2,55,58  
To reduce hypothermia, frequently associated with clipping of the fur, asepsis and prolonged 
recovery time, towels or heating pads can be used to elevate the body temperature58, which 
should be carefully monitored.62 Stressful environments (noises, odour and sight of potential 
predators)62 have a negative impact on rabbits recovery due to the stimulation of the sympathetic 
nervous system and consequently decreasing of gastrointestinal motility.58 Physiological 
parameters such as respiratory and heart are also affected and should be monitorized.58 Although 
it is a rare complication, a recent study presented 3 cases of colonic obstruction after 
ovariohysterectomy, in which clinical signs such as decreased appetite, anorexia, abdominal pain 
and decreased faecal output were present.63 To avoid a decreased gastrointestinal motility, a 
gastrointestinal kinetic stimulant such as metoclopramide (0,2-0,5 mg/kg PO, SC, every 6 to 8 
hours)57 should be administrated if the rabbit is anorexic or does not defecate within 24-48h after 
the surgery.55,58  
Rabbits and rodents present very subtle signs of pain making it difficult to assess.55,58 Signs like 
absence of grooming, crouched position and tooth grinding are suggestive of postoperative 
pain.55,58 The presence of such signs should determinate whether further analgesics should be 
given.55 To guarantee an adequate analgesia, association of opioids such as butorphanol (0,1-
0,5 mg/kg SC, IM, IV, every 4 hours)57 or buprenorphine (0,03 mg/kg IM every 12 hours)57 and 
non-steroidal analgesics such as carprofen (1-2,2 mg/kg PO every 12 hours)57 or meloxicam (0,2 
mg/kg SC, IM, every 24 hours)57 can be done without adverse effects on rabbits.58  
Palatable food (Critical Care®) and water should be available right after the rabbit is 
recovered2,55,58,62 to ensure gut motility is restored as soon as possible.55 
At the time of surgery, metastatic disease may not be macroscopically visible during diagnosis 
imaging or laparoscopy. Having said that, re-examination of the patient every 3 to 6 months for 1 
to 2 years after the surgical treatment is recommended to detect metastatic disease.9,21,50,52,62 In 
a recent study, pulmonary metastasis were detected in 4 rabbits, 2, 3, 5 and 8 months after 
undergoing the surgical treatment described earlier (Figure 10.).52 
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Figure 10. Pulmonary metastasis detected in a laterolateral thoracic radiograph of a rabbit with uterine 
adenocarcinoma.  
Courtesy of Dr. Neus Morera, Clinica Veterinaria Exótics, Barcelona, Spain 
 
6.2 Oncological treatment 
In addition to surgery, the use of chemotherapy, radiotherapy and hormonal therapy could be 
hypothesised in the treatment of the rabbit uterine adenocarcinoma. However, effective treatment 
using these therapies has not yet been reported.21,22  
Admitting that there are no official approved chemotherapy agents for use in exotic animals, the 
few reports of chemotherapy in rabbits result from the use of canine and feline protocols adapted 
to the rabbit.64,65 As described in Table 4., several chemotherapy agents have been experimented 
in rabbits, mainly in a laboratory setting but also in pet rabbits.66,64  One of the main limitations of 
the chemotherapy use in rabbits is the toxicity.64,65 In fact, moderate to severe myelosupression 
with associated neutropenia and gastrointestinal toxicity are two of the main effects described 
mainly in laboratory animals with induced tumours. 64,66  
Regarding radiotherapy, there is also very little literature regarding its utilization alone and in 
combination with surgery and/or with chemotherapy.65 In women, the treatment of endometrial 
tumours with radiation therapy involves two techniques: external beam radiation, which consists 
of a machine that focuses a beam of radiation at the tumour, meaning that the treatment is 
delivered from a source outside the body, and brachytherapy or internal radiation therapy, a 
technique in which radioactive materials are placed near the tumour, inside the body.67 
Information regarding the association of these techniques and the treatment of uterine 
adenocarcinoma in veterinary medicine articles has not been found. 
Relatively to the use of hormonal therapy in the treatment of the rabbit uterine adenocarcinoma 
little is known. As a matter of fact, the use of this type of therapy can only be considered after an 
adequate study of the oestrogen receptor expression in rabbit endometrial tumours. In women, 
hormonal therapy based on progestins, luteinizing hormone-releasing hormone agonists, 
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aromatase inhibitors and tamoxifen is one of the main therapeutic methods in the treatment of 
hormone-dependent tumours. Therefore, in rabbits, to determine the role of hormonal therapy it 
is important to make an exhaustive analysis of the contribution of hormones for the development 
of this tumour.  
 
a. Progestins 
Progestins such as medroxyprogesterone acetate and megestrol acetate are drugs that 
present similarity to progesterone. Their function is to slow the growth of the endometrial 
tumour.68  
 
b. Luteinizing hormone-releasing hormone agonists 
In women with functioning ovaries this agonist is given to inhibit the production of oestrogens 
and consequently to lower the oestrogen level in the body. Goserelin and leuprolide are some 
of the drugs with this effect.68  
 
c. Aromatase inhibitors 
Aromatase inhibitors are used to block the enzyme aromatase which converts testosterone 
to oestrogens, leading to a decrease in oestrogen production in the tumour tissues. An in vitro 
treatment of endometrial tumour tissue with the aromatase inhibitors showed that in situ 
depletion of oestrogen leads to a lower proliferation of tumour cells.69 Examples of aromatase 
inhibitors are letrozole, anastrozole and exemestane. They are most frequently used in the 
treatment of mammary neoplasia and its therapy success towards more advanced 
endometrial tumours is still unclear.68,69 
 
d. Tamoxifen 
Tamoxifen is an anti-oestrogen nonsteroidal drug used commonly in the treatment of 
mammary tumours from different species including the rabbit. It binds to the oestrogen 
receptors present in the body, including the ones in the tumour tissue, blocking their activity.3 
 
 
Table 4. Chemotherapy agents and dosage recommendations for rabbits.  
Chemotherapy Agent Dosage 
Carboplatin 150-180 mg/m² IV, every 21-28 days 
Lomustine (CCNU) 50 mg/m² PO, every 3-6 weeks 
Cyclophosphamide 5-6 mg/m² IV, every 21 days 
Doxorubicin 1 mg/kg IV, every 14-21 days 
L-asparaginase 400 U/kg SC, IV 
Mitoxantrone 5-6 mg/m² IV, every 21 days 
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Prednisone 0.5-2 mg/kg PO 
Vincristine 0.5-0.7 mg/m² IV, every 7-14 days 
Adapted from Mayer et al. (2013). 
 
7. Prognosis 
If surgical treatment is performed prior to metastatic disease or associated mammary neoplasia, 
the prognosis of the uterine adenocarcinoma is considered excellent and frequently curative in 
clinically stable patients.7,9,22,50 In case of metastatic spread, the prognosis is poor, since there is 
no oncological treatment considered successful. In these cases the survival rate is approximately 
12 to 24 months upon the diagnosis.7,22 Moreover, to reach an accurate prognosis, evaluation of 
the physical condition of the patient is essential51, since a poor clinical condition is associated 
with a worse prognosis9. Euthanasia should only be considered in the referred cases.9,52 
According to Saito et al., the mortality rate immediately after ovariohysterectomy was 21.3%.51 
However, according Kunzel et al., when rabbits survive to surgery the survival rate at 6 months 
was 80% 9, and, in a similar study performed by Walter et al. 52, the survival rate at two years was 
28%.  
 
 
8. Prevention 
Prevention is the answer when it comes to the management of uterine adenocarcinoma.7,21,50 In 
spite of the fact that the contribution of hormones to tumour development is not yet well 
investigated, female rabbit owners that are not considering breeding should be advised to neuter 
their pet as soon as the procedure can be done and before they reach 2 years of age.7,50 It is 
preferable to spay the rabbit between 6 and 12 months since at an early age ovariohysterectomy 
tends to be less complicated due to less fat content of the abdomen, and healing time is minimal 
in comparison with older rabbits. 7,21,22 Although the procedure can be done after 4 to 5 months 
of age, neutering of a pre-pubescent female is not recommended on account that it can be difficult 
to clearly identify  the uterus and ovaries since they are not fully developed.28  
When it comes to breeding rabbits, it is recommended to stop breeding and perform 
ovariohysterectomy before it reaches 4 years of age, time when the incidence of uterine tumours 
is higher.22 Before that, annual or semi-annual health examinations should be done to control and 
detect possible early clinical signs of the disease.7,21 
Educating the client to the benefits of neutering must start at the pet rabbit’s first visit.21 Besides 
preventing the appearance of uterine adenocarcinoma, neutering is also advisable to reduce 
behavioural problems, prevent unwanted pregnancies, pseudopregnancies, and reproductive 
diseases such as uterine and mammary neoplasia, endometritis and uterine infections like 
pyometra.2,28 
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9. Future perspectives 
The rabbit as a clinical patient and as one of the favourite pet choices for owners is still a recent 
accomplishment, which means that the medicine regarding this species may not be as evolved 
as it is for other small and production animals. The majority of study cases and articles about 
uterine adenocarcinoma in rabbits only present surgery as the procedure to treat this tumour or 
in advanced cases euthanasia, without much further exploration into other possibilities of 
treatments that are currently being applied to humans and other species.  
Therefore, a more profound study of the cellular, molecular and genetic alterations that 
characterize the uterine adenocarcinoma in rabbits is urgent. Similar to what happened in 
humans, dogs and cats, this exhaustive study will allow the identification of gene mutations, the 
study of alterations in signalling pathways and the contribution of hormones to the tumour 
development. Once rabbit uterine adenocarcinoma is adequately characterized it will be possible 
to achieve an accurate diagnosis and to establish new treatment protocols that may significantly 
increase the quality of life and survival upon diagnosis. 
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